睾酮对跨性别与性别多元人群宫颈阴道细胞学的影响
本研究回顾性分析2012至2019年间211例跨性别与性别多元(TGD)患者的298份宫颈细胞学检查,比较睾酮相关标本与非睾酮标本的标本质量和细胞学结果。结果显示睾酮相关标本更易出现转化区缺失、萎缩或细胞量不足(58.8% vs 33.5%,P < .001)及炎症(16.0% vs 3.4%,P < .001),但异常结果比例无显著差异。
要点
- 睾酮相关宫颈细胞学标本转化区缺失、萎缩或细胞量不足比例更高。
- 睾酮相关标本炎症比例更高,但异常细胞学结果无显著差异。
- 需进一步研究转化区缺失对未来宫颈病变风险的影响。
核心结论
- 睾酮使用与宫颈细胞学标本质量和 adequacy 相关,但与异常结果率无关。
研究设计与样本
- 回顾性电子健康记录审查,纳入211例有宫颈的TGD患者,贡献298份独特宫颈细胞学检查,就诊于初级保健诊所,时间2012至2019年。
主要发现
- 睾酮相关标本转化区缺失、萎缩或细胞量不足比例高于非睾酮标本(58.8% vs 33.5%,P < .001)。
- 睾酮相关标本炎症比例高于非睾酮标本(16.0% vs 3.4%,P < .001)。
- 两组异常结果比例无显著差异。
关键数值与推荐
- 主要结局包括标本质量(转化区存在、转化区缺失、萎缩标本、细胞量不足)、炎症存在与否及细胞学结果(正常、异常、标本不足)。
- 使用χ2检验和t检验比较睾酮相关标本与非睾酮标本。
临床怎么用
- 解读TGD患者宫颈细胞学时应考虑睾酮使用对标本质量的影响。
- 睾酮使用不改变异常细胞学结果率,但标本不足可能影响筛查准确性。
局限性
- 回顾性设计,样本来自单一初级保健诊所,可能限制普遍性。
- 需更多研究区分转化区缺失对未来宫颈病变风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Papanicolaou (Papanicolaou) test is an effective and widely used cervical cancer screening procedure. Recommendations for cervical cancer screening do not incorporate patients' gender identities nor gender-affirming hormone statuses in determining screening surveillance intervals and interpreting test results. This study assessed the association between testosterone and rates of abnormal Papanicolaou specimens and specimen adequacy by comparing testosterone-associated Papanicolaou specimens and nontestosterone Papanicolaou specimens among transgender and gender-diverse (TGD) patients. METHODS: Retrospective electronic health record chart review of 211 TGD patients with cervixes, contributing 298 unique Papanicolaou tests, with a visit to a primary care clinic between 2012 and 2019. Primary outcomes included specimen quality (transformation zone [TZ] present, TZ absent, atrophic specimen, scant cellularity), presence of inflammation (yes/no), and cytology results (normal, abnormal, inadequate specimen). χ2 and t test were used to compare results between testosterone-associated Papanicolaou specimens (TAPS) and nontestosterone specimens (NTS). RESULTS: A higher proportion of TAPS had missing TZ, showed atrophy, or had scant cellularity than NTPS (58.8% vs 33.5%; P < .001). In addition, a higher proportion of TAPS showed inflammation (16.0% vs 3.4%; P < .001). There was no significant difference in the proportion of abnormal results (ie, cytologic features concerning for dysplasia) between the TAPS and NTPS groups. CONCLUSIONS: Findings confirmed an association between testosterone usage and cytology specimen adequacy and quality. No association was found between testosterone usage and rates of abnormal results within our TGD population. More research is needed to disentangle the effect of missing TZ on risk of future cervical dysplasia among this younger population.
引用
- Chen D, Erroba J, Liu S, et al. The Effects of Testosterone on Cervicovaginal Cytology in Transgender and Gender-Diverse Individuals. J Am Board Fam Med. 2024. PMID: 40118539. doi:10.3122/jabfm.2023.230468R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。